Mobilizing Parkinson's Disease: The Future of Exercise

被引:99
|
作者
Ellis, Terry [1 ]
Rochester, Lynn [2 ,3 ]
机构
[1] Boston Univ, Coll Hlth & Rehabil Sci, Sargent Coll, Ctr Neurorehabil, 635 Commonwealth Ave, Boston, MA 02215 USA
[2] Newcastle Univ, Inst Neurosci, Newcastle Upon Tyne, Tyne & Wear, England
[3] Newcastle Upon Tyne Hosp NHS Fdn Trust, Newcastle Upon Tyne, Tyne & Wear, England
关键词
Parkinson's disease; exercise; rehabilitation; disease modification;
D O I
10.3233/JPD-181489
中图分类号
Q189 [神经科学];
学科分类号
071006 ;
摘要
Exercise is increasingly recognized as an important element in the treatment of Parkinson's disease but what is exercise targeting? What accounts for the benefits observed in Parkinson's disease? Is exercise disease modifying? Several modes of exercise have been studied in various doses across a heterogeneous Parkinson's population. Yet more clarity is needed as to who benefits most and when, from what type of exercise and at which intensity. In this paper, we briefly review the state of the art in key areas and speculate on the likely state of research in each area in the next 20 years. Key areas relate to: (1) the physiological benefits of exercise with respect to disease modification; (2) the best type of exercise; (3) the optimal intensity of exercise; and (4) implementation strategies to increase exercise uptake. A better understanding of these concepts would allow for a more effective, personalized approach, rather than the current "one size fits all" and could most likely confer greater benefits.
引用
收藏
页码:S95 / S100
页数:6
相关论文
共 50 条
  • [41] Subthalamotomy for Parkinson's disease: back to the future?
    Volkmann, Jens
    LANCET NEUROLOGY, 2018, 17 (01): : 23 - 24
  • [42] Parkinson's Disease - the Future of Invasive Therapy
    Deuschl, G.
    FORTSCHRITTE DER NEUROLOGIE PSYCHIATRIE, 2010, 78 : S16 - S19
  • [43] Neuroimaging in Parkinson's disease: a future perspective
    Brooks, David J.
    NEURODEGENERATIVE DISEASE MANAGEMENT, 2015, 5 (02) : 105 - 108
  • [44] The Future of Hospitalization for People with Parkinson's Disease
    Wallis, A.
    Perret, D.
    MOVEMENT DISORDERS, 2020, 35 : S145 - S146
  • [45] Present and future selves in Parkinson's disease
    Ernst, Alexandra
    Allen, Joanne
    Dubourg, Lydia
    Souchay, Celine
    NEUROCASE, 2017, 23 (3-4) : 210 - 219
  • [46] Biomarkers of Parkinson's disease: Present and future
    Miller, Diane B.
    O'Callaghan, James P.
    METABOLISM-CLINICAL AND EXPERIMENTAL, 2015, 64 (03): : S40 - S46
  • [47] Past, Present, and Future of Parkinson's Disease
    Gershanik, Oscar S.
    MOVEMENT DISORDERS, 2017, 32 (09) : 1263 - 1263
  • [48] The future of pharmacogenetics in Parkinson's disease treatment
    Hutz, Mara H.
    Rieder, Carlos R. M.
    PHARMACOGENOMICS, 2018, 19 (03) : 171 - 174
  • [49] Future therapeutic options in Parkinson's!disease
    Wuellner, U.
    Buhmann, C.
    Hilker, R.
    Hummel, S.
    Korchounov, A.
    Mueller, T.
    Paulus, W.
    Schwartz, A.
    AKTUELLE NEUROLOGIE, 2007, 34 : S18 - S20
  • [50] The Future of Surgical Treatments for Parkinson's Disease
    Lee, Darrin J.
    Lozano, Andres M.
    JOURNAL OF PARKINSONS DISEASE, 2018, 8 : S79 - S83